Vultaggio Vincent (CIK 2018766) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-10). Recent activity: Sell ZNTL (29,951 shares), Sell ZNTL (3,379 shares), Sell ZNTL (6,894 shares), Sell ZNTL (2,540 shares), Sell ZNTL (556 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and PFO | Sell | 29,951 | $72,781 |
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and PFO | Sell | 3,379 | $8,076 |
| 2026-02-10 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and PFO | Sell | 6,894 | $16,683 |
| 2026-02-04 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and PFO | Sell | 2,540 | $6,477 |
| 2026-02-04 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and PFO | Sell | 556 | $1,401 |
| 2025-02-05 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and Interim PFO | Buy | 158,586 | $0 |
| 2025-02-05 | Zentalis Pharmaceuticals, Inc. (ZNTL) | PAO and Interim PFO | Sell | 2,615 | $4,472 |
Source: SEC Form 4 filings · as of 2026-02-10